
Invicta Diagnostic IPO Listed at a 17.65% Premium on NSE at ₹100
Invicta Diagnostic IPO is listed with a premium of 17.65% at ₹100 on the NSE (National Stock Exchange). The IPO GMP was ₹0 last heard.

Invicta Diagnostic IPO is listed with a premium of 17.65% at ₹100 on the NSE (National Stock Exchange). The IPO GMP was ₹0 last heard.

Astron Multigrain IPO is listed with a discount of 20% at ₹50.40 on the BSE (Bombay Stock Exchange). The IPO GMP was 0 last heard.

Clear Secured IPO is listed with a discount of 9.85% at ₹119 on the NSE (National Stock Exchange). The IPO GMP of this IPO was ₹3 last heard.

Ravelcare IPO is listed with a premium of 54.62% at ₹201 on the BSE (Bombay Stock Exchange). The IPO GMP was ₹75 last heard.

Speb Adhesives IPO is listed with a premium of 7.14% at ₹60 on the NSE (National Stock Exchange). The IPO GMP of this IPO was ₹0 last heard.

Check out Ravelcare IPO GMP aka IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates as of today. Ravelcare IPO GMP is started in grey market. Stay tuned

Check out Clear Secured IPO GMP aka IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates as of today. Clear Secured IPO GMP is started in grey market.

The Speb Adhesives IPO allotment status is now available on the allotment date on December 4, 2025, Thursday. The Speb Adhesives IPO subscription was ended on December 3, 2025, Wednesday.

The Astron Multigrain IPO allotment status is now available on the allotment date on December 4, 2025, Thursday. The Astron Multigrain IPO subscription was ended on December 3, 2025, Wednesday.

The Clear Secured Services IPO allotment status is now available on the allotment date on December 4, 2025, Thursday. The Clear Secured Services IPO subscription was ended on December 3,

The Ravelcare IPO allotment status is now available on the allotment date on December 4, 2025, Thursday. The Ravelcare IPO subscription was ended on December 3, 2025, Wednesday.
The investors

The Invicta Diagnostic IPO allotment status is now available on the allotment date on December 4, 2025, Thursday. The Invicta Diagnostic IPO subscription was ended on December 3, 2025, Wednesday.